Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1987 Dec;76:49–56. doi: 10.1289/ehp.877649

An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.

H C Pitot 1, H A Campbell 1
PMCID: PMC1474468  PMID: 2896122

Abstract

The potency of carcinogenic agents in eliciting neoplastic lesions has long been a concern of investigators in the field of oncology. This paper describes a method, based on quantitative stereologic calculations, to estimate the relative potency of chemicals as initiating and/or promoting agents. The parameters defined in this paper are: (a) Initiation index = no. foci induced X liver-1 X [mmole/kg body weight]-1; and (b) Promotion index = Vf/Vc X mmol-1 X wk-1. These parameters have been calculated for a number of chemical agents, based both on data from this laboratory and others published in the literature. Neither parameter varied significantly with the dose of two different initiating agents used in this study. The range of promotion indices extended over more than eight orders of magnitude, whereas that of the initiation indices was much less variable. Such parameters may be useful as quantitative estimates of the potency of hepatocarcinogenic agents not only in rodents, but potentially in quantitative risk estimations in the human.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge W. N. The biological basis and measurement of thresholds. Annu Rev Pharmacol Toxicol. 1986;26:39–58. doi: 10.1146/annurev.pa.26.040186.000351. [DOI] [PubMed] [Google Scholar]
  2. Ames B. N. The detection of environmental mutagens and potential carcinogens. Cancer. 1984 May 15;53(10):2034–2040. doi: 10.1002/1097-0142(19840515)53:10<2034::aid-cncr2820531005>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  3. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  4. Barr J. T. The calculation and use of carcinogenic potency: a review. Regul Toxicol Pharmacol. 1985 Dec;5(4):432–459. doi: 10.1016/0273-2300(85)90008-x. [DOI] [PubMed] [Google Scholar]
  5. Boberg E. W., Liem A., Miller E. C., Miller J. A. Inhibition by pentachlorophenol of the initiating and promoting activities of 1'-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver. Carcinogenesis. 1987 Apr;8(4):531–539. doi: 10.1093/carcin/8.4.531. [DOI] [PubMed] [Google Scholar]
  6. Bohrman J. S. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods. Crit Rev Toxicol. 1983;11(2):121–167. doi: 10.3109/10408448309089850. [DOI] [PubMed] [Google Scholar]
  7. Campbell H. A., Pitot H. C., Potter V. R., Laishes B. A. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 1982 Feb;42(2):465–472. [PubMed] [Google Scholar]
  8. Campbell H. A., Xu Y. D., Hanigan M. H., Pitot H. C. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J Natl Cancer Inst. 1986 Apr;76(4):751–767. doi: 10.1093/jnci/76.4.751. [DOI] [PubMed] [Google Scholar]
  9. Diamond L., O'Brien T. G., Baird W. M. Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res. 1980;32:1–74. doi: 10.1016/s0065-230x(08)60360-7. [DOI] [PubMed] [Google Scholar]
  10. Emmelot P., Scherer E. The first relevant cell stage in rat liver carcinogenesis. A quantitative approach. Biochim Biophys Acta. 1980 May 6;605(2):247–304. doi: 10.1016/0304-419x(80)90006-2. [DOI] [PubMed] [Google Scholar]
  11. Farber E., Sarma D. S. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest. 1987 Jan;56(1):4–22. [PubMed] [Google Scholar]
  12. Glauert H. P., Beer D., Rao M. S., Schwarz M., Xu Y. D., Goldsworthy T. L., Coloma J., Pitot H. C. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Res. 1986 Sep;46(9):4601–4606. [PubMed] [Google Scholar]
  13. Glauert H. P., Beer D., Rao M. S., Schwarz M., Xu Y. D., Goldsworthy T. L., Coloma J., Pitot H. C. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Res. 1986 Sep;46(9):4601–4606. [PubMed] [Google Scholar]
  14. Goldsworthy T. L., Hanigan M. H., Pitot H. C. Models of hepatocarcinogenesis in the rat--contrasts and comparisons. Crit Rev Toxicol. 1986;17(1):61–89. doi: 10.3109/10408448609037071. [DOI] [PubMed] [Google Scholar]
  15. Goldsworthy T. L., Pitot H. C. An approach to the development of a short-term whole-animal bioassay to distinguish initiating agents (incomplete carcinogens), promoting agents, complete carcinogens, and noncarcinogens in rat liver. J Toxicol Environ Health. 1985;16(3-4):389–402. doi: 10.1080/15287398509530749. [DOI] [PubMed] [Google Scholar]
  16. Goldsworthy T., Campbell H. A., Pitot H. C. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis. 1984 Jan;5(1):67–71. doi: 10.1093/carcin/5.1.67. [DOI] [PubMed] [Google Scholar]
  17. Hanigan M. H., Pitot H. C. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital. Cancer Res. 1985 Dec;45(12 Pt 1):6063–6070. [PubMed] [Google Scholar]
  18. Hendrich S., Campbell H. A., Pitot H. C. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis. 1987 Sep;8(9):1245–1250. doi: 10.1093/carcin/8.9.1245. [DOI] [PubMed] [Google Scholar]
  19. Hendrich S., Glauert H. P., Pitot H. C. The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital. Carcinogenesis. 1986 Dec;7(12):2041–2045. doi: 10.1093/carcin/7.12.2041. [DOI] [PubMed] [Google Scholar]
  20. Herren S. L., Pereira M. A., Britt A. L., Khoury M. K. Initiation/promotion assay for chemical carcinogens in rat liver. Toxicol Lett. 1982 Jul;12(2-3):143–150. doi: 10.1016/0378-4274(82)90177-1. [DOI] [PubMed] [Google Scholar]
  21. Hiasa Y., Kitahori Y., Ohshima M., Fujita T., Yuasa T., Konishi N., Miyashiro A. Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis. 1982;3(10):1187–1190. doi: 10.1093/carcin/3.10.1187. [DOI] [PubMed] [Google Scholar]
  22. Ito N., Tatematsu M., Nakanishi K., Hasegawa R., Takano T., Imaida K., Ogiso T. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gan. 1980 Dec;71(6):832–842. [PubMed] [Google Scholar]
  23. Klein-Szanto A. J., Major S. K., Slaga T. J. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis. 1980 May;1(5):399–406. doi: 10.1093/carcin/1.5.399. [DOI] [PubMed] [Google Scholar]
  24. Lutz W. K., Büsser M. T., Sagelsdorff P. Potency of carcinogens derived from covalent DNA binding and stimulation of DNA synthesis in rat liver. Toxicol Pathol. 1984;12(1):106–111. doi: 10.1177/019262338401200118. [DOI] [PubMed] [Google Scholar]
  25. Malvaldi G., Chieli E., Saviozzi M. Promotive effects of thiobenzamide on liver carcinogenesis. Gan. 1983 Aug;74(4):469–471. [PubMed] [Google Scholar]
  26. Moore M. A., Kitagawa T. Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro. Int Rev Cytol. 1986;101:125–173. doi: 10.1016/s0074-7696(08)60248-x. [DOI] [PubMed] [Google Scholar]
  27. Moore M. A., Nakagawa K., Satoh K., Ishikawa T., Sato K. Single GST-P positive liver cells--putative initiated hepatocytes. Carcinogenesis. 1987 Mar;8(3):483–486. doi: 10.1093/carcin/8.3.483. [DOI] [PubMed] [Google Scholar]
  28. Mori H., Tanaka T., Takahashi M., Williams G. M. Exclusion of cellular iron and reduced gamma-glutamyl transpeptidase activity in rat pancreas acinar cell hyperplastic nodules and adenomas induced by azaserine. Gan. 1983 Aug;74(4):497–501. [PubMed] [Google Scholar]
  29. Naito M., Naito Y., Ito A. Effect of phenobarbital on the development of tumors in mice treated neonatally with N-ethyl-N-nitrosourea. Gan. 1982 Feb;73(1):111–114. [PubMed] [Google Scholar]
  30. O'Connell J. F., Klein-Szanto A. J., DiGiovanni D. M., Fries J. W., Slaga T. J. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res. 1986 Jun;46(6):2863–2865. [PubMed] [Google Scholar]
  31. Ohshima M., Ward J. M. Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats. Cancer Res. 1986 Feb;46(2):877–883. [PubMed] [Google Scholar]
  32. Parodi S., Taningher M., Santi L. Induction of preneoplastic nodules: quantitative predictivity of carcinogenicity. Anticancer Res. 1983 Nov-Dec;3(6):393–399. [PubMed] [Google Scholar]
  33. Peraino C., Staffeldt E. F., Carnes B. A., Ludeman V. A., Blomquist J. A., Vesselinovitch S. D. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 1984 Aug;44(8):3340–3347. [PubMed] [Google Scholar]
  34. Peraino C., Staffeldt E. F., Ludeman V. A. Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis. 1981;2(5):463–465. doi: 10.1093/carcin/2.5.463. [DOI] [PubMed] [Google Scholar]
  35. Perera F. P. The genotoxic/epigenetic distinction: relevance to cancer policy. Environ Res. 1984 Jun;34(1):175–191. doi: 10.1016/0013-9351(84)90087-2. [DOI] [PubMed] [Google Scholar]
  36. Pitot H. C., Barsness L., Goldsworthy T., Kitagawa T. Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 1978 Feb 2;271(5644):456–458. doi: 10.1038/271456a0. [DOI] [PubMed] [Google Scholar]
  37. Pitot H. C., Goldsworthy T. L., Moran S., Kennan W., Glauert H. P., Maronpot R. R., Campbell H. A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis. 1987 Oct;8(10):1491–1499. doi: 10.1093/carcin/8.10.1491. [DOI] [PubMed] [Google Scholar]
  38. Pitot H. C., Goldsworthy T., Campbell H. A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 1980 Oct;40(10):3616–3620. [PubMed] [Google Scholar]
  39. Pitot H. C., Sirica A. E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta. 1980 May 6;605(2):191–215. doi: 10.1016/0304-419x(80)90004-9. [DOI] [PubMed] [Google Scholar]
  40. Purnell D. M. The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats. Am J Pathol. 1980 Feb;98(2):311–324. [PMC free article] [PubMed] [Google Scholar]
  41. Rabes H. M., Bücher T., Hartmann A., Linke I., Dünnwald M. Clonal growth of carcinogen-induced enzyme-deficient preneoplastic cell populations in mouse liver. Cancer Res. 1982 Aug;42(8):3220–3227. [PubMed] [Google Scholar]
  42. Ross M. H., Lustbader E. D., Bras G. Dietary practices of early life and age at death of rats with tumors. J Natl Cancer Inst. 1983 Nov;71(5):947–954. [PubMed] [Google Scholar]
  43. Russell J. J., Staffeldt E. F., Wright B. J., Prapuolenis A., Carnes B. A., Peraino C. Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine. Cancer Res. 1987 Feb 15;47(4):1130–1134. [PubMed] [Google Scholar]
  44. Scherer E., Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat. Eur J Cancer. 1975 Oct;11(10):689–696. doi: 10.1016/0014-2964(75)90042-0. [DOI] [PubMed] [Google Scholar]
  45. Scherer E., Hoffmann M. Probable clonal genesis of cellular islands induced in rat liver by diethylnitrosamine. Eur J Cancer. 1971 Aug;7(4):369–371. doi: 10.1016/0014-2964(71)90083-1. [DOI] [PubMed] [Google Scholar]
  46. Schulte-Hermann R. Tumor promotion in the liver. Arch Toxicol. 1985 Aug;57(3):147–158. doi: 10.1007/BF00290879. [DOI] [PubMed] [Google Scholar]
  47. Schwarz M., Pearson D., Port R., Kunz W. Promoting effect of 4-dimethylaminoazobenzene on enzyme altered foci induced in rat liver by N-nitrosodiethanolamine. Carcinogenesis. 1984 Jun;5(6):725–730. doi: 10.1093/carcin/5.6.725. [DOI] [PubMed] [Google Scholar]
  48. Scribner J. D., Süss R. Tumor initiation and promotion. Int Rev Exp Pathol. 1978;18:137–198. [PubMed] [Google Scholar]
  49. Slaga T. J. Overview of tumor promotion in animals. Environ Health Perspect. 1983 Apr;50:3–14. doi: 10.1289/ehp.83503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stenbäck F. Tumor persistence and regression in skin carcinogenesis. An experimental study. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978;91(3):249–259. doi: 10.1007/BF00312287. [DOI] [PubMed] [Google Scholar]
  51. Tatematsu M., Mera Y., Ito N., Satoh K., Sato K. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis. 1985 Nov;6(11):1621–1626. doi: 10.1093/carcin/6.11.1621. [DOI] [PubMed] [Google Scholar]
  52. Tsuda H., Hasegawa R., Imaida K., Masui T., Moore M. A., Ito N. Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver. Gan. 1984 Oct;75(10):876–883. [PubMed] [Google Scholar]
  53. Weinberg W. C., Berkwits L., Iannaccone P. M. The clonal nature of carcinogen-induced altered foci of gamma-glutamyl transpeptidase expression in rat liver. Carcinogenesis. 1987 Apr;8(4):565–570. doi: 10.1093/carcin/8.4.565. [DOI] [PubMed] [Google Scholar]
  54. Witschi H. R., Morse C. C. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: dose-time relationships and cell kinetics. J Natl Cancer Inst. 1983 Oct;71(4):859–866. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES